These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 29035828)
1. The role of CIP2A in cancer: A review and update. Soofiyani SR; Hejazi MS; Baradaran B Biomed Pharmacother; 2017 Dec; 96():626-633. PubMed ID: 29035828 [TBL] [Abstract][Full Text] [Related]
2. Cancerous inhibitor of protein phosphatase 2A, an emerging human oncoprotein and a potential cancer therapy target. Khanna A; Pimanda JE; Westermarck J Cancer Res; 2013 Nov; 73(22):6548-53. PubMed ID: 24204027 [TBL] [Abstract][Full Text] [Related]
3. MYC-dependent regulation and prognostic role of CIP2A in gastric cancer. Khanna A; Böckelman C; Hemmes A; Junttila MR; Wiksten JP; Lundin M; Junnila S; Murphy DJ; Evan GI; Haglund C; Westermarck J; Ristimäki A J Natl Cancer Inst; 2009 Jun; 101(11):793-805. PubMed ID: 19470954 [TBL] [Abstract][Full Text] [Related]
4. Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands. De P; Carlson J; Leyland-Jones B; Dey N Oncotarget; 2014 Jul; 5(13):4581-602. PubMed ID: 25015035 [TBL] [Abstract][Full Text] [Related]
5. CIP2A modulates cell-cycle progression in human cancer cells by regulating the stability and activity of Plk1. Kim JS; Kim EJ; Oh JS; Park IC; Hwang SG Cancer Res; 2013 Nov; 73(22):6667-78. PubMed ID: 23983103 [TBL] [Abstract][Full Text] [Related]
6. CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells. Chen KF; Liu CY; Lin YC; Yu HC; Liu TH; Hou DR; Chen PJ; Cheng AL Oncogene; 2010 Nov; 29(47):6257-66. PubMed ID: 20729919 [TBL] [Abstract][Full Text] [Related]
7. CIP2A signature reveals the MYC dependency of CIP2A-regulated phenotypes and its clinical association with breast cancer subtypes. Niemelä M; Kauko O; Sihto H; Mpindi JP; Nicorici D; Pernilä P; Kallioniemi OP; Joensuu H; Hautaniemi S; Westermarck J Oncogene; 2012 Sep; 31(39):4266-78. PubMed ID: 22249265 [TBL] [Abstract][Full Text] [Related]
8. Cancerous inhibitor of PP2A (CIP2A) at diagnosis of chronic myeloid leukemia is a critical determinant of disease progression. Lucas CM; Harris RJ; Giannoudis A; Copland M; Slupsky JR; Clark RE Blood; 2011 Jun; 117(24):6660-8. PubMed ID: 21490338 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of CIP2A is an independent prognostic indicator in nasopharyngeal carcinoma and its depletion suppresses cell proliferation and tumor growth. Liu N; He QM; Chen JW; Li YQ; Xu YF; Ren XY; Sun Y; Mai HQ; Shao JY; Jia WH; Kang TB; Zeng MS; Ma J Mol Cancer; 2014 May; 13():111. PubMed ID: 24884612 [TBL] [Abstract][Full Text] [Related]
10. Cancerous inhibitor of protein phosphatase 2A is overexpressed in cervical cancer and upregulated by human papillomavirus 16 E7 oncoprotein. Liu J; Wang X; Zhou G; Wang H; Xiang L; Cheng Y; Liu W; Wang Y; Jia J; Zhao W Gynecol Oncol; 2011 Aug; 122(2):430-6. PubMed ID: 21575984 [TBL] [Abstract][Full Text] [Related]
11. CIP2A inhibits PP2A in human malignancies. Junttila MR; Puustinen P; Niemelä M; Ahola R; Arnold H; Böttzauw T; Ala-aho R; Nielsen C; Ivaska J; Taya Y; Lu SL; Lin S; Chan EK; Wang XJ; Grènman R; Kast J; Kallunki T; Sears R; Kähäri VM; Westermarck J Cell; 2007 Jul; 130(1):51-62. PubMed ID: 17632056 [TBL] [Abstract][Full Text] [Related]
12. FL118 inhibits viability and induces apoptosis of colorectal cancer cells via inactivating the CIP2A/PP2A axis. Lin X; Gao M; Zhang A; Tong J; Zhang X; Su Q; Yang Z; Gao H; Jiang G Life Sci; 2019 Dec; 239():117074. PubMed ID: 31751585 [TBL] [Abstract][Full Text] [Related]
13. Clinical significance of cancerous inhibitor of protein phosphatase 2A in human cancers. Khanna A; Pimanda JE Int J Cancer; 2016 Feb; 138(3):525-32. PubMed ID: 25628223 [TBL] [Abstract][Full Text] [Related]
14. CIP2A oncoprotein controls cell growth and autophagy through mTORC1 activation. Puustinen P; Rytter A; Mortensen M; Kohonen P; Moreira JM; Jäättelä M J Cell Biol; 2014 Mar; 204(5):713-27. PubMed ID: 24590173 [TBL] [Abstract][Full Text] [Related]
15. p90/CIP2A mediates breast cancer cell proliferation and apoptosis. Liu X; Peng B; Li Y; Lei N; Li W; Zhang JY Mol Biol Rep; 2014 Nov; 41(11):7471-8. PubMed ID: 25086622 [TBL] [Abstract][Full Text] [Related]
16. CIP2A is associated with human breast cancer aggressivity. Côme C; Laine A; Chanrion M; Edgren H; Mattila E; Liu X; Jonkers J; Ivaska J; Isola J; Darbon JM; Kallioniemi O; Thézenas S; Westermarck J Clin Cancer Res; 2009 Aug; 15(16):5092-100. PubMed ID: 19671842 [TBL] [Abstract][Full Text] [Related]
17. CIP2A, an oncoprotein, is associated with cell proliferation, invasion and migration in laryngeal carcinoma cells. Chen XD; Tang SX; Zhang JH; Zhang LT; Wang YW Oncol Rep; 2017 Aug; 38(2):1005-1012. PubMed ID: 28656258 [TBL] [Abstract][Full Text] [Related]
18. Effect of CIP2A and its mechanism of action in the malignant biological behavior of colorectal cancer. Chen W; Liang JL; Zhou K; Zeng QL; Ye JW; Huang MJ Cell Commun Signal; 2020 Apr; 18(1):67. PubMed ID: 32321509 [TBL] [Abstract][Full Text] [Related]
19. Cucurbitacin B reverses multidrug resistance by targeting CIP2A to reactivate protein phosphatase 2A in MCF-7/adriamycin cells. Cai F; Zhang L; Xiao X; Duan C; Huang Q; Fan C; Li J; Liu X; Li S; Liu Y Oncol Rep; 2016 Aug; 36(2):1180-6. PubMed ID: 27350399 [TBL] [Abstract][Full Text] [Related]
20. CIP2A is overexpressed in human endometrioid adenocarcinoma and regulates cell proliferation, invasion and apoptosis. Yu N; Zhang T; Zhao D; Cao Z; Du J; Zhang Q Pathol Res Pract; 2018 Feb; 214(2):233-239. PubMed ID: 29274810 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]